The microarray market size has grown strongly in recent years. It will grow from $5.19 billion in 2024 to $5.63 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to genomic research surge, rise in personalized medicine, pharmaceutical drug discovery, advancements in cancer research, biotechnology and life sciences expansion.
The microarray market size is expected to see rapid growth in the next few years. It will grow to $8.27 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to rapid growth in molecular diagnostics, emergence of precision medicine, increased adoption in agriculture, expansion of microbiome research, technological integration in healthcare. Major trends in the forecast period include enhancements in microarray data analysis tools, focus on biomarker discovery for neurological disorders, utilization in infectious disease research, adoption in functional genomics studies, increasing applications in drug discovery and development.
The future growth of the microarray market is anticipated to be driven by the increasing incidence of cancer cases. Cancer, characterized by uncontrolled cell growth and spread to other parts of the body, is on the rise due to factors such as established risk factors, exposure to specific chemicals, an aging population, and prevalent cancers such as breast cancer, lung cancer, and bronchial cancer. Microarray technology plays a crucial role in cancer research by enabling the identification of changes in gene expression associated with the disease. For example, the American Cancer Society estimates that around 9,910 children under the age of 15 will be diagnosed with cancer in the US in 2023, with approximately 1,040 children expected to succumb to the disease. Therefore, the increasing incidence of cancer cases is a key driver for the growth of the microarray market.
The expanding pharmaceutical industry is expected to drive the growth of the microarray market in the future. This sector encompasses the discovery, development, and production of drugs and medicines by both governmental and private organizations. Microarray technology is utilized within the pharmaceutical industry for detailed analysis of gene expression, genetic variations, and molecular interactions, supporting advanced research in drug discovery, development, and personalized medicine. For instance, in May 2024, data from the UK Health Accounts for 2022 and 2023, published by the UK Office for National Statistics, indicated that total healthcare expenditure increased by 5.6% in nominal terms between 2022 and 2023, a substantial rise compared to the 0.9% growth observed in 2022. Thus, the growth of the pharmaceutical industry is propelling the microarray market forward.
A noteworthy trend in the microarray market is the emphasis on product innovation by major market players. These companies are actively working on creating innovative products to strengthen their market position. For instance, in August 2023, Thermo Fisher Scientific, Inc., a US-based supplier of analytical instruments, life sciences solutions, and biotechnology services, launched the Applied Biosystems CytoScan HD Accel array. This chromosomal microarray is designed to enhance productivity, efficiency, and profitability in cytogenetic research labs, boasting an industry-leading two-day turnaround time. It offers comprehensive analysis of the entire human genome with enhanced coverage across 5,000 critical genomic regions, providing valuable insights into chromosomal variants for applications such as prenatal and postnatal research, as well as cancer-related studies.
Leading companies in the microarray market are focusing on the development of chromosomal microarrays to solidify their market position. Chromosomal Microarray Analysis (CMA) is considered a transformative technology in genomic medicine, significantly advancing diagnostic capabilities. For instance, in August 2023, Thermo Fisher Scientific Inc. introduced the Applied Biosystems CytoScan HD Accel array, contributing to improved productivity, efficiency, and profitability in cytogenetic research labs. This microarray facilitates comprehensive analysis of chromosomal variants for a broad range of research applications, including prenatal, postnatal, and oncology studies.
In May 2024, Bruker, a U.S.-based manufacturer of analytical instrumentation and scientific solutions, acquired NanoString's business for an undisclosed sum. This acquisition is intended to bolster Bruker's position in the life sciences sector and enhance its portfolio of analytical tools and solutions. NanoString is a U.S.-based biotechnology company known for producing DNA and protein microarrays as well as biosensors.
Major companies operating in the microarray market include Agilent Technologies Inc., Arrayit Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, GE Healthcare Inc., Illumina Inc., Merck KGaA, Microarray Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., Molecular Devices LLC, RayBiotech Life Inc., NextGen Sciences Inc., PathogenDx Inc., Schott Minifab AG, Full Moon Biosystems Inc., CapitalBio Technology Co. Ltd., Roche Diagnostics, Ltd., BioGenomics Limited, BioMicro Systems Inc., Biostatus Limited, Biotechrabbit GmbH, Affymetrix Inc., SCIENION AG, INanoBio Inc.
North America was the largest region in the microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global microarray market report during the forecast period. The regions covered in the microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Microarray is a widely employed laboratory technique that involves affixing numerous known nucleic acid fragments - ranging from tens of thousands to millions - onto a solid surface, commonly referred to as a chip. This method finds frequent application in scientific and medical research, serving purposes such as detecting specific DNA sequences and assessing gene expression.
The primary categories of microarrays include DNA microarray, protein microarray, and others. A DNA microarray consists of small DNA spots affixed to a solid substrate, utilized to determine the presence of gene mutations, such as those in BRCA1 or BRCA2, within the DNA of a particular individual. This technology is employed across various domains, including disease diagnosis, cancer genomic analysis, drug discovery, genomic sequencing, expression analysis, and toxicological research. Its users span the pharmaceutical and biotechnology industries, academic and research laboratories, and other end-users.
The microarray market research report is one of a series of new reports that provides microarray market statistics, including the microarray industry’s global market size, regional shares, competitors with a microarray market share, detailed microarray market segments, market trends, and opportunities, and any further data you may need to thrive in the microarray industry. This microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The microarray market consists of revenues earned by entities by providing services such as genotyping and methylation array services, analytical protein microarray, functional protein array, reverse-phase protein array, and peptide microarray. The value of associated goods sold by the service provider or incorporated into the service providing is included in the market value. The microarray market also includes sales of microarray slides or chips and priming, microarray fluorescence and colorimetric scanners, printers, hybridization stations or DNA and RNA assays, whole genome sequencing, cDNA Microarray, BAC microarray, oligo microarray, which are used in providing microarray services. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The microarray market size is expected to see rapid growth in the next few years. It will grow to $8.27 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to rapid growth in molecular diagnostics, emergence of precision medicine, increased adoption in agriculture, expansion of microbiome research, technological integration in healthcare. Major trends in the forecast period include enhancements in microarray data analysis tools, focus on biomarker discovery for neurological disorders, utilization in infectious disease research, adoption in functional genomics studies, increasing applications in drug discovery and development.
The future growth of the microarray market is anticipated to be driven by the increasing incidence of cancer cases. Cancer, characterized by uncontrolled cell growth and spread to other parts of the body, is on the rise due to factors such as established risk factors, exposure to specific chemicals, an aging population, and prevalent cancers such as breast cancer, lung cancer, and bronchial cancer. Microarray technology plays a crucial role in cancer research by enabling the identification of changes in gene expression associated with the disease. For example, the American Cancer Society estimates that around 9,910 children under the age of 15 will be diagnosed with cancer in the US in 2023, with approximately 1,040 children expected to succumb to the disease. Therefore, the increasing incidence of cancer cases is a key driver for the growth of the microarray market.
The expanding pharmaceutical industry is expected to drive the growth of the microarray market in the future. This sector encompasses the discovery, development, and production of drugs and medicines by both governmental and private organizations. Microarray technology is utilized within the pharmaceutical industry for detailed analysis of gene expression, genetic variations, and molecular interactions, supporting advanced research in drug discovery, development, and personalized medicine. For instance, in May 2024, data from the UK Health Accounts for 2022 and 2023, published by the UK Office for National Statistics, indicated that total healthcare expenditure increased by 5.6% in nominal terms between 2022 and 2023, a substantial rise compared to the 0.9% growth observed in 2022. Thus, the growth of the pharmaceutical industry is propelling the microarray market forward.
A noteworthy trend in the microarray market is the emphasis on product innovation by major market players. These companies are actively working on creating innovative products to strengthen their market position. For instance, in August 2023, Thermo Fisher Scientific, Inc., a US-based supplier of analytical instruments, life sciences solutions, and biotechnology services, launched the Applied Biosystems CytoScan HD Accel array. This chromosomal microarray is designed to enhance productivity, efficiency, and profitability in cytogenetic research labs, boasting an industry-leading two-day turnaround time. It offers comprehensive analysis of the entire human genome with enhanced coverage across 5,000 critical genomic regions, providing valuable insights into chromosomal variants for applications such as prenatal and postnatal research, as well as cancer-related studies.
Leading companies in the microarray market are focusing on the development of chromosomal microarrays to solidify their market position. Chromosomal Microarray Analysis (CMA) is considered a transformative technology in genomic medicine, significantly advancing diagnostic capabilities. For instance, in August 2023, Thermo Fisher Scientific Inc. introduced the Applied Biosystems CytoScan HD Accel array, contributing to improved productivity, efficiency, and profitability in cytogenetic research labs. This microarray facilitates comprehensive analysis of chromosomal variants for a broad range of research applications, including prenatal, postnatal, and oncology studies.
In May 2024, Bruker, a U.S.-based manufacturer of analytical instrumentation and scientific solutions, acquired NanoString's business for an undisclosed sum. This acquisition is intended to bolster Bruker's position in the life sciences sector and enhance its portfolio of analytical tools and solutions. NanoString is a U.S.-based biotechnology company known for producing DNA and protein microarrays as well as biosensors.
Major companies operating in the microarray market include Agilent Technologies Inc., Arrayit Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, GE Healthcare Inc., Illumina Inc., Merck KGaA, Microarray Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., Molecular Devices LLC, RayBiotech Life Inc., NextGen Sciences Inc., PathogenDx Inc., Schott Minifab AG, Full Moon Biosystems Inc., CapitalBio Technology Co. Ltd., Roche Diagnostics, Ltd., BioGenomics Limited, BioMicro Systems Inc., Biostatus Limited, Biotechrabbit GmbH, Affymetrix Inc., SCIENION AG, INanoBio Inc.
North America was the largest region in the microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global microarray market report during the forecast period. The regions covered in the microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Microarray is a widely employed laboratory technique that involves affixing numerous known nucleic acid fragments - ranging from tens of thousands to millions - onto a solid surface, commonly referred to as a chip. This method finds frequent application in scientific and medical research, serving purposes such as detecting specific DNA sequences and assessing gene expression.
The primary categories of microarrays include DNA microarray, protein microarray, and others. A DNA microarray consists of small DNA spots affixed to a solid substrate, utilized to determine the presence of gene mutations, such as those in BRCA1 or BRCA2, within the DNA of a particular individual. This technology is employed across various domains, including disease diagnosis, cancer genomic analysis, drug discovery, genomic sequencing, expression analysis, and toxicological research. Its users span the pharmaceutical and biotechnology industries, academic and research laboratories, and other end-users.
The microarray market research report is one of a series of new reports that provides microarray market statistics, including the microarray industry’s global market size, regional shares, competitors with a microarray market share, detailed microarray market segments, market trends, and opportunities, and any further data you may need to thrive in the microarray industry. This microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The microarray market consists of revenues earned by entities by providing services such as genotyping and methylation array services, analytical protein microarray, functional protein array, reverse-phase protein array, and peptide microarray. The value of associated goods sold by the service provider or incorporated into the service providing is included in the market value. The microarray market also includes sales of microarray slides or chips and priming, microarray fluorescence and colorimetric scanners, printers, hybridization stations or DNA and RNA assays, whole genome sequencing, cDNA Microarray, BAC microarray, oligo microarray, which are used in providing microarray services. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Microarray Market Characteristics3. Microarray Market Trends and Strategies4. Microarray Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Microarray Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Microarray Market34. Recent Developments in the Microarray Market
5. Global Microarray Growth Analysis and Strategic Analysis Framework
6. Microarray Market Segmentation
7. Microarray Market Regional and Country Analysis
8. Asia-Pacific Microarray Market
9. China Microarray Market
10. India Microarray Market
11. Japan Microarray Market
12. Australia Microarray Market
13. Indonesia Microarray Market
14. South Korea Microarray Market
15. Western Europe Microarray Market
16. UK Microarray Market
17. Germany Microarray Market
18. France Microarray Market
19. Italy Microarray Market
20. Spain Microarray Market
21. Eastern Europe Microarray Market
22. Russia Microarray Market
23. North America Microarray Market
24. USA Microarray Market
25. Canada Microarray Market
26. South America Microarray Market
27. Brazil Microarray Market
28. Middle East Microarray Market
29. Africa Microarray Market
30. Microarray Market Competitive Landscape and Company Profiles
31. Microarray Market Other Major and Innovative Companies
35. Microarray Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Microarray Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on microarray market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for microarray? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The microarray market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: DNA Microarray; Protein Microarray; Other Types2) By Application: Disease Diagnosis; Cancer Genomic Analysis; Drug Discovery; Genomic Sequencing; Expression Analysis; Toxicological Research; Other Applications
3) By End-User: Pharmaceutical Industry; Biotechnology Industry; Academic and Research Laboratories; Other End-Users
Subsegments:
1) By DNA Microarray: CDNA Microarray; Oligonucleotide Microarray; SNP Microarray; Comparative Genomic Hybridization (CGH) Microarray2) By Protein Microarray: Antibody Microarray; Antigen Microarray; Receptor Microarray; Enzyme Microarray
3) By Other Types: Cell Microarray; Tissue Microarray; RNA Microarray
Key Companies Mentioned: Agilent Technologies Inc.; Arrayit Corporation; Bio-Rad Laboratories Inc.; Danaher Corporation; GE Healthcare Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Agilent Technologies Inc.
- Arrayit Corporation
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- GE Healthcare Inc.
- Illumina Inc.
- Merck KGaA
- Microarray Inc.
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
- Molecular Devices LLC
- RayBiotech Life Inc.
- NextGen Sciences Inc.
- PathogenDx Inc.
- Schott Minifab AG
- Full Moon Biosystems Inc.
- CapitalBio Technology Co. Ltd.
- Roche Diagnostics
- Ltd.
- BioGenomics Limited
- BioMicro Systems Inc.
- Biostatus Limited
- Biotechrabbit GmbH
- Affymetrix Inc.
- SCIENION AG
- INanoBio Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 5.63 Billion |
| Forecasted Market Value ( USD | $ 8.27 Billion |
| Compound Annual Growth Rate | 10.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
